Q32 BIO

Q32 Bio is a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. Q32 Bio's lead programs, focused on the IL-7 / TSLP receptor pathways and complement system, address immune dysregulation to help patients take back control of their lives... Q32 Bio is comprised of an experienced and high-performing team of industry professionals including talented scientists, immunologists, and drug developers empowered to deliver on OUR mission... Q32 Bio is developing drugs targeting powerful regulators of both the innate and adaptive immune systems with the goal of re-balancing the immune system.

Also known as: Q32 Bio Inc.

Primary location: Waltham United States